NKGen Biotech (NKGN) Stock Chart & Stock Price History $0.0002 -0.10 (-99.80%) As of 10/3/2025 01:19 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NKGen Biotech Stock Price Performance The NKGen Biotech (NKGN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.95%, with a year-to-date return of -99.97%. In the past month, the stock has decreased 99.85%, reflecting recent market activity. As of the latest close, NKGen Biotech traded at $0.00 with a market cap of $9 thousand and volume of 500 shares. Receive NKGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-99.82%1 Month Performance-99.85%3 Month Performance-99.93%Year-To-Date Performance-99.97%1 Year Performance-99.95% NKGN Stock Chart for Saturday, October, 4, 2025 NKGN Chart by TradingView NKGen Biotech Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/03/2025$0.10$0.00-99.80%$0.10$0.00500 shs$9,000.0010/02/2025$0.11$0.10-9.09%$0.11$0.007,808 shs$4.50 million10/01/2025$0.11$0.11$0.11$0.1125 shs$4.94 million09/30/2025$0.11$0.11$0.11$0.1125 shs$4.94 million09/29/2025$0.11$0.11$0.11$0.112,603 shs$4.94 million09/26/2025$0.11$0.11$0.11$0.112,603 shs$4.94 million09/25/2025$0.11$0.11$0.11$0.113,551 shs$4.94 million09/24/2025$0.11$0.11$0.11$0.118,605 shs$4.94 million09/23/2025$0.11$0.11$0.11$0.113,457 shs$4.94 million09/22/2025$0.13$0.11-16.98%$0.12$0.112,101 shs$4.94 million Get the Latest News and Ratings for NKGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter. 09/19/2025$0.14$0.13-3.99%$0.13$0.1320,333 shs$5.96 million09/18/2025$0.13$0.14+4.15%$0.14$0.1310,901 shs$6.20 million09/17/2025$0.13$0.13$0.13$0.13982 shs$5.96 million09/16/2025$0.13$0.13$0.13$0.13982 shs$5.96 million09/15/2025$0.13$0.13$0.13$0.1326,440 shs$5.96 million09/12/2025$0.13$0.13$0.13$0.13130 shs$5.96 million09/11/2025$0.14$0.13-7.02%$0.14$0.131,325 shs$5.96 million09/10/2025$0.13$0.14+7.55%$0.14$0.131,667 shs$6.41 million09/09/2025$0.15$0.13-11.67%$0.13$0.1311,066 shs$5.96 million09/08/2025$0.14$0.15+5.26%$0.15$0.1310,724 shs$6.74 million09/05/2025$0.13$0.14+7.55%$0.14$0.136,964 shs$6.41 million09/04/2025$0.13$0.13$0.13$0.13542 shs$5.96 million09/03/2025$0.13$0.13$0.20$0.13401 shs$5.96 million Related Companies Citius Pharmaceuticals Stock Price Chart Finch Therapeutics Group Stock Price Chart Flora Growth Stock Price Chart Talphera Stock Price Chart Abpro Stock Price Chart Natural Alternatives International Stock Price Chart ProPhase Labs Stock Price Chart Neuphoria Therapeutics Stock Price Chart Ainos Stock Price Chart Cellectar Biosciences Stock Price Chart Receive NKGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for NKGen Biotech and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:NKGN) was last updated on 10/4/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingThe warning signs that preceded the 2008 crash are reappearing: an irrational NASDAQ bubble, a record-high gol...StockEarnings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredNvidia’s slow death marchEric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredChina’s New Gold Play Could Make your Income SoarChina's New Gold Move Could Pay You up to $1,152/month. China just announced plans to store other nations' ...Investors Alley | SponsoredLost Decade warning – do this nowWith the Magnificent 7 trading at bubble-like valuations, another “Lost Decade” could be looming — but Porter ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NKGen Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NKGen Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
